首页 / 产品 / 抗体 / 一抗

Rabbit Monoclonal SF3B1 Antibody

  • 中文名: SF3B1抗体
  • 别    名: Hsh 155; MDS; PRP10; PRPF10; SAP155; SF3B 1; SF3b155;;SF3B1
货号: IPDX18065
Price: ¥1280
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC IHC:1/100-1/200;IHF:1/50-1/200 Human,Mouse,Rat
ICC 1/50-1/200 Human,Mouse,Rat
FCM 1/20-1/100 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

AliasesIBP2; IGF-BP53
Entrez GeneID3485
clone1F6F6
Host/IsotypeMouse IgG1
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenPurified recombinant fragment of protein IGFBP2 (aa180-328) expressed in E. Coli.  
FormulationPurified antibody in PBS with 0.05% sodium azide.

+ +

参考文献

以下是关于SF3B1抗体的3篇参考文献及其摘要概括:

---

1. **文献名称**:*Recurrent mutations in the splicing factor SF3B1 in chronic lymphocytic leukemia*

**作者**:Quesada V, et al.

**摘要内容**:该研究通过全基因组测序发现慢性淋巴细胞白血病(CLL)中SF3B1基因的反复突变,并开发了特异性抗体用于检测突变蛋白的表达,揭示了SF3B1异常剪接与白血病进展的关联。

---

2. **文献名称**:*SF3B1 mutations are associated with specific allelic losses and transcriptional profiles in myelodysplastic syndromes*

**作者**:Malcovati L, et al.

**摘要内容**:研究利用SF3B1特异性抗体进行免疫组织化学分析,证明骨髓增生异常综合征(MDS)患者中SF3B1突变与特定染色体缺失和异常RNA剪接模式相关,为疾病分型提供了分子标志物。

---

3. **文献名称**:*Antibody-based detection of aberrant splicing factor mutations in solid tumors*

**作者**:Wang L, et al.

**摘要内容**:该文献报道了一种新型SF3B1抗体的开发与验证,应用于实体瘤样本的免疫荧光检测,证实SF3B1突变在部分癌症(如乳腺癌和胰腺癌)中的表达异常及其潜在诊断价值。

---

这些文献涵盖了SF3B1抗体在突变检测、疾病机制研究和临床诊断中的应用。如需具体文章链接或补充更多文献,可进一步说明。

背景信息

The SF3B1 antibody targets the SF3B1 (Splicing Factor 3B Subunit 1) protein, a core component of the spliceosome responsible for pre-mRNA processing. SF3B1 plays a critical role in recognizing branch site sequences during the splicing process, ensuring precise removal of introns and ligation of exons. Mutations in the *SF3B1* gene are frequently observed in cancers such as myelodysplastic syndromes (MDS), chronic lymphocytic leukemia (CLL), and uveal melanoma, often correlating with aberrant splicing and disease progression. Antibodies against SF3B1 are widely used in research to study its expression, localization, and interaction partners in normal and pathological contexts. They enable detection of SF3B1 protein levels via techniques like Western blotting, immunohistochemistry, or immunofluorescence, aiding in understanding its role in splicing dysregulation. Additionally, SF3B1 antibodies help identify mutant variants or assess post-translational modifications linked to cellular stress or therapeutic resistance. Their diagnostic potential is emerging, particularly in hematologic malignancies, where SF3B1 mutations serve as biomarkers for prognosis or targeted therapy. However, challenges remain in distinguishing wild-type from mutant isoforms using standard antibodies, driving the development of mutation-specific reagents. Overall, SF3B1 antibodies are vital tools for unraveling splicing biology and its implications in disease.

客户数据及评论

折叠内容

大包装询价

×